Prognostic Markers in Thrombolytic Therapy: Looking Beyond Mortality

This publication has 15 references indexed in Scilit:

• Prognostic Importance of Myocardial Ischemia Detected by Ambulatory Monitoring Early after Acute Myocardial Infarction
  New England Journal of Medicine, 1996
• Benefit of Thrombolytic Therapy Is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge
  Circulation, 1995
• Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis
  American Heart Journal, 1995
• Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario experience, 1981 to 1991
  Journal of the American College of Cardiology, 1994
• A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent: A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-derived analysis
  Journal of the American College of Cardiology, 1994
• Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators.
  Circulation, 1994
• Trends in acute myocardial infarction coronary heart disease death in the United States
  Journal of the American College of Cardiology, 1994
• Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis
  Journal of the American College of Cardiology, 1991
• Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.
  Heart, 1990
• Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function.
  Heart, 1990